Lonza Netherlands, former PharmaCell Competitors, Revenue, Alternatives and Pricing

Claim your profile


Maastricht, Netherlands
Total Funding:N/A
Lead Investor(s):N/A

Estimated Revenue & Financials

  • Lonza Netherlands, former PharmaCell's estimated annual revenue is currently $55.3M per year.(?)
  • Lonza Netherlands, former PharmaCell's estimated revenue per employee is $201,000

Employee Data

  • Lonza Netherlands, former PharmaCell has 275 Employees.(?)
  • Lonza Netherlands, former PharmaCell grew their employee count by 35% last year.
  • Lonza Netherlands, former PharmaCell currently has 1 job openings.

Lonza Netherlands is a Contract Manufacturing Organization (CMO) in the area of cell therapy and regenerative medicine (tissue culturing). The company works with European and US-based biotechnology companies on pre-clinical, clinical to commercial development projects and offers GMP and regulatory consultancy, cell culturing process development, fill and finish, Quality Control (QC)-testing and Good Manufacturing Practices (GMP) production services, as well as storage and distribution of clinical trial materials. PharmaCell is located in the center of Europe and operates two state-of-the-art cGMP-licensed facilities for human cell & tissue culturing in Maastricht and Geleen (Netherlands), conveniently located at approximately one hour driving distance from Brussels, Antwerp, Cologne and Dusseldorf.